Aaron Kesselheim was quoted on FDA's Law Blog.

Aaron Kesselheim (2011 Awardee) was quoted in the blog post, "Congress Continues Spree of Proposing Alternative Incentives for Product Development: the 'CBRN Countermeasure PRV'" on the FDA's Law Blog, October 22, 2015.